Plasmacytoid variant of bladder cancer defines patients with poor prognosis if treated with cystectomy and adjuvant cisplatin-based chemotherapy

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Keck, Bastian ^a   Wach, Sven ^a   Stoehr, Robert ^a   Kunath, Frank ^a   Bertz, Simone ^a   Lehmann, Jan ^b   Stöckle, Michael ^c   Taubert, Helge ^a   Wullich, Bernd ^a   Hartmann, Arndt ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b Urology Practice   (Germany)

^c SAARLAND UNIVERSITY   (Germany)

Author keywords

ChemotherapyCystectomyMicropapillaryPlasmacytoidPrognosis; Urinary bladder neoplasm

Indexed keywords

CISPLATIN; EPIRUBICIN; GEMCITABINE; METHOTREXATE; VINBLASTINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; CONTROLLED STUDY; FEMALE; HAZARD RATIO; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROPAPILLARY CARCINOMA OF THE BLADDER; OVERALL SURVIVAL; PLASMACYTOID UROTHELIAL CARCINOMA OF THE BLADDER; RANDOMIZED CONTROLLED TRIAL; WORLD HEALTH ORGANIZATION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA; CARCINOMA, PAPILLARY; CHEMOTHERAPY, ADJUVANT; CISPLATIN; CYSTECTOMY; FEMALE; GERMANY; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 84873417441     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-71     Document Type: Article

References (25)

1. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in europe in 2008. J Cancer 2010, 46(4):765-781.
2. Classification of tumours. Pathology and genetics of the tumours of the urinary system and male genital organs 2004, Lyon: World Health Organization, Eble JSG, Epstein JI, Sesterhenn IA.
3. Keck B, Stoehr R, Wach S, Rogler A, Nolte E, Hartmann A, Wullich B. Plasmacytoid and micropapillary urothelial carcinoma: rare forms of urothelial carcinoma. Der Urologe Ausg A 2011, 50(2):217-220. 10.1007/s00120-010-2484-4, 21246348.
4. Keck B, Stoehr R, Wach S, Rogler A, Hofstaedter F, Lehmann J, Montironi R, Sibonye M, Fritsche HM, Lopez-Beltran A, et al. The plasmacytoid carcinoma of the bladder-rare variant of aggressive urothelial carcinoma. Int J Cancer Journal International du Cancer 2011, 129(2):346-354.
5. Amin MB, Ro JY, el-Sharkawy T, Lee KM, Troncoso P, Silva EG, Ordonez NG, Ayala AG. Micropapillary variant of transitional cell carcinoma of the urinary bladder. Histologic pattern resembling ovarian papillary serous carcinoma. Am J Surg Pathol 1994, 18(12):1224-1232. 10.1097/00000478-199412000-00005, 7977945.
6. Alkibay T, Sozen S, Gurocak S, Isik Gonul I, Poyraz A, Ure I. Micropapillary pattern in urothelial carcinoma: a clinicopathological analysis. Urol Int 2009, 83(3):300-305. 10.1159/000241672, 19829030.
7. Lopez-Beltran A, Montironi R, Blanca A, Cheng L. Invasive micropapillary urothelial carcinoma of the bladder. Hum Pathol 2010, 41(8):1159-1164. 10.1016/j.humpath.2009.11.018, 20381120.
8. Edgerton N, Sirintrapun SJ, Munoz M, Chen Z, Osunkoya AO. Micropapillary urothelial carcinoma of the urinary bladder: a clinicopathological analysis of 24 cases. Int J Urology 2011, 18(1):49-54.
9. Lehmann J, Retz M, Wiemers C, Beck J, Thuroff J, Weining C, Albers P, Frohneberg D, Becker T, Funke PJ, et al. Adjuvant cisplatin plus methotrexate versus methotrexate, vinblastine, epirubicin, and cisplatin in locally advanced bladder cancer: results of a randomized, multicenter, phase III trial (AUO-AB 05/95). J Clin Oncol 2005, 23(22):4963-4974. 10.1200/JCO.2005.11.094, 15939920.
10. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Eur Urol 2005, 48(2):189-199. discussion 199-201, 10.1016/j.eururo.2005.04.005, 15939530, Advanced Bladder Cancer (ABC) Meta-analysis Collaboration.
11. Advanced Bladder Cancer (ABC) Meta-analysis Collaboration Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Eur Urol 2005, 48(2):202-205. discussion 205-206, 10.1016/j.eururo.2005.04.006, 15939524, Advanced Bladder Cancer (ABC) Meta-analysis Collaboration.
12. Stenzl A, Cowan NC, De Santis M, Kuczyk MA, Merseburger AS, Ribal MJ, Sherif A, Witjes JA. Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines. Eur Urol 2011, 59(6):1009-1018. 10.1016/j.eururo.2011.03.023, 21454009.
13. Shapur NK, Katz R, Pode D, Shapiro A, Yutkin V, Pizov G, Appelbaum L, Zorn KC, Duvdevani M, Landau EH, et al. Is radical cystectomy mandatory in every patient with variant histology of bladder cancer. Rare tumors 2011, 3(2):e22. 3132126, 21769321.
14. Hayashi T, Tanigawa G, Fujita K, Imamura R, Nakazawa S, Yamamoto Y, Hosomi M, Shimazu K, Fushimi H, Yamaguchi S. Two cases of plasmacytoid variant of urothelial carcinoma of urinary bladder: systemic chemotherapy might be of benefit. Int J Clin Oncol/Jpn Soc Clin Oncol 2011, 16(6):759-762.
15. McConkey DJ, Choi W, Marquis L, Martin F, Williams MB, Shah J, Svatek R, Das A, Adam L, Kamat A, et al. Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer. Cancer Metastasis Rev 2009, 28(3-4):335-344.
16. Shiota M, Song Y, Yokomizo A, Kiyoshima K, Tada Y, Uchino H, Uchiumi T, Inokuchi J, Oda Y, Kuroiwa K, et al. Foxo3a Suppression of urothelial cancer invasiveness through Twist1, Y-box-binding protein 1, and E-cadherin regulation. Clin Cancer Res 2010, 16(23):5654-5663. 10.1158/1078-0432.CCR-10-0376, 21138866.
17. Verdu M, Roman R, Calvo M, Rodon N, Garcia B, Gonzalez M, Vidal A, Puig X. Clinicopathological and molecular characterization of colorectal micropapillary carcinoma. Mod Pathol 2011, 24(5):729-738. 10.1038/modpathol.2011.1, 21336262.
18. Siriaunkgul S, Tavassoli FA. Invasive micropapillary carcinoma of the breast. Mod Pathol 1993, 6(6):660-662.
19. Lotan TL, Ye H, Melamed J, Wu XR, Shih Ie M, Epstein JI. Immunohistochemical panel to identify the primary site of invasive micropapillary carcinoma. Am J Surg Pathol 2009, 33(7):1037-1041. 10.1097/PAS.0b013e3181962dcd, 3484367, 19238079.
20. Ching CB, Amin MB, Tubbs RR, Elson P, Platt E, Dreicer R, Fergany A, Hansel DE. HER2 Gene amplification occurs frequently in the micropapillary variant of urothelial carcinoma: analysis by dual-color in situ hybridization. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc 2011, 24(8):1111-1119.
21. Ghoneim IA, Miocinovic R, Stephenson AJ, Garcia JA, Gong MC, Campbell SC, Hansel DE, Fergany AF. Neoadjuvant systemic therapy or early cystectomy? single-center analysis of outcomes after therapy for patients with clinically localized micropapillary urothelial carcinoma of the bladder. Urology 2011, 77(4):867-870. 10.1016/j.urology.2010.11.043, 21296399.
22. Comperat E, Roupret M, Yaxley J, Reynolds J, Varinot J, Ouzaid I, Cussenot O, Samaratunga H. Micropapillary urothelial carcinoma of the urinary bladder: a clinicopathological analysis of 72 cases. Pathology 2010, 42(7):650-654. 10.3109/00313025.2010.522173, 21080874.
23. Sangoi AR, Beck AH, Amin MB, Cheng L, Epstein JI, Hansel DE, Iczkowski KA, Lopez-Beltran A, Oliva E, Paner GP, et al. Interobserver reproducibility in the diagnosis of invasive micropapillary carcinoma of the urinary tract among urologic pathologists. Am J Surg Pathol 2010, 34(9):1367-1376. 10.1097/PAS.0b013e3181ec86b3, 20717002.
24. Kamat AM, Dinney CP, Gee JR, Grossman HB, Siefker-Radtke AO, Tamboli P, Detry MA, Robinson TL, Pisters LL. Micropapillary bladder cancer: a review of the university of texas M. D. Anderson cancer center experience with 100 consecutive patients. Cancer 2007, 110(1):62-67. 10.1002/cncr.22756, 17542024.
25. Heudel P, El Karak F, Ismaili N, Droz JP, Flechon A. Micropapillary bladder cancer: a review of leon berard cancer center experience. BMC Urol 2009, 9:5. 10.1186/1471-2490-9-5, 2713271, 19534791.